Institution statistics

BOEHRINGER INGELHEIM PHARMA GMBH &CO KG -

Ranking results:

Past rankings:

2019
Criterium:	Position:
Overall Score:	500-600
Total Project Funding per Partner:	> 1000
Total Number of Projects:	300-400
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Networking Rank (Reputation):	> 1000
2016
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 30
As coordinator: 0
As participant: 30
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2021	0	34.601.665	0		2
2020	0	85.107.848	252.788		5
2019	0	45.677.464	252.788		5
2018	0	15.942.861	0		2
2017	0	55.675.195	0		6
2016	0	33.556.083	463.820		4
2013	0	6.485.847	0		1
2012	0	11.174.600	307.640		2
2010	0	9.834.779	0		3

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
NOVARTIS PHARMA	11
PFIZER LIMITED	10
JANSSEN PHARMACEUTICA NV	9
BAYER	7
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	7
ABBVIE INC	6
F HOFFMANNLA ROCHE	6
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	6
NOVO NORDISK	6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	6
UCB BIOPHARMA	6
ELI LILLY AND COMPANY LIMITED	5
INSTITUT DE RECHERCHES SERVIER	5
KATHOLIEKE UNIVERSITEIT LEUVEN	5
LEIDS UNIVERSITAIR MEDISCH CENTRUM	5
UNIVERSITAET BERN	5
UNIVERSITY OF DUNDEE	5
ASTRAZENECA	4
ASTRAZENECA AB	4
EBERHARD KARLS UNIVERSITAET TUEBINGEN	4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	4
MEDIZINISCHE UNIVERSITAET WIEN	4
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT	4
ASTELLAS PHARMA EUROPE BV	3
BAYER AKTIENGESELLSCHAFT	3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH	3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	3
EUROPEAN MOLECULAR BIOLOGY LABORATORY	3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER	3
JDRF INTERNATIONAL	3
LUNDS UNIVERSITET	3
MEDIZINISCHE UNIVERSITAT INNSBRUCK	3
MERCK SHARP & DOHME CORP	3
SANOFIAVENTIS	3
SANOFIAVENTIS DEUTSCHLAND	3
TAKEDA PHARMACEUTICALS INTERNATIONAL	3
THE UNIVERSITY OF LIVERPOOL	3
UNIVERSITAETSKLINIKUM FREIBURG	3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT	3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	3
UNIVERSITAT WIEN	3
UNIVERSITEIT LEIDEN	3
UNIVERSITEIT MAASTRICHT	3
UNIVERSITY OF HELSINKI	3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	2
ALLERGAN LIMITED	2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	2
CERTARA UK LIMITED	2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS	2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM	2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	2
LINKOPINGS UNIVERSITET	2
LIPOTYPE	2
MEDTRONIC INTERNATIONAL TRADING SARL	2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE	2
ORION OYJ	2
OWKIN FRANCE	2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE	2
STATENS LEGEMIDDELVERK	2
STICHTING KATHOLIEKE UNIVERSITEIT	2
STICHTING LYGATURE	2
STICHTING VUMC	2
SYDDANSK UNIVERSITET	2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	2
TAKEDA DEVELOPMENT CENTRE EUROPE	2
TECHNISCHE UNIVERSITAET MUENCHEN	2
THE UNIVERSITY OF EDINBURGH	2
THE UNIVERSITY OF EXETER	2
THE UNIVERSITY OF NOTTINGHAM	2
TRANSGENE	2
UNIVERSITA CATTOLICA DEL SACRO CUORE	2
UNIVERSITAET ZU LUEBECK	2
UNIVERSITAETSKLINIKUM AACHEN	2
UNIVERSITAETSKLINIKUM JENA	2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ	2
UNIVERSITE DU LUXEMBOURG	2
UNIVERSITEIT TWENTE	2
UNIVERSITEIT UTRECHT	2
UNIVERSITY OF BIRMINGHAM	2
UNIVERSITY OF LEEDS	2
UNIVERSITY OF OSLO	2
UPPSALA UNIVERSITET	2
WEIZMANN INSTITUTE OF SCIENCE	2
ABBVIE DEUTSCHLAND GMBH & CO KG	1
ACADEMISCH ZIEKENHUIS GRONINGEN	1
ADELPHI VALUES	1
AIBIOPHARMA	1
AICURIS ANTIINFECTIVE CURES	1
AMC MEDICAL RESEARCH BV	1
AMGEN	1
AMGEN RESEARCH	1
ANTAROS MEDICAL AB	1
APPLIED RESEARCH USING OMIC SCIENCES SL	1
ARLENDA	1
ARTEEVO TECHNOLOGIES	1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS	1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA	1

Constancy:

Total number of partners:579

Partner loyalty:
Frequent Partner: (> 2 projects): 201
Rare Partner: 378

Frequent / Rare Partner Ratio: 0.53

Diversity:

Subjects:

Subject:	No:
EDUCATION	1
NETWORK TECHNOLOGIES	1
TRAINING	1

Diversity index:0.43

Categories:

Category:	No:
INDUSTRY AND TECHNOLOGY	1
SOCIAL AND ECONOMIC CONCERNS	1

Project overview:

Start date	Project	acronym	role	funding	partners
2021-02-01	Central Repository for Digital Pathology	BIGPICTURE	participant	32.319.825	45
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2020-06-01	Stratification of Obese Phenotypes to Optimize Future Obesity Therapy	SOPHIA	participant	8.301.000	29
2020-05-01	EUbOPEN: Enabling and Unlocking biology in the OPEN	EUbOPEN	participant	27.935.000	22
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	37
2020-01-01	PharmaLedger	PharmaLedger	participant	8.290.694	29
2020-01-01	INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.	INSPIRE	participant	4.021.969	11
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	33
2019-09-01	Proton transport and proton-coupled transport	PROTON	participant	3.976.976	12
2019-06-01	MachinE Learning Ledger Orchestration for Drug DiscoverY	MELLODDY	participant	8.000.000	17
2019-05-01	ENdoThelial macRophage Alliance In Neuroinflammation	ENTRAIN	participant	3.664.174	20
2018-12-01	Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe	EUROoC	participant	3.942.861	21
2018-07-01	Research empowerment on solute carriers (ReSOLUTE)	ReSOLUTE	participant	12.000.000	14
2017-11-01	Liver Investigation: Testing Marker Utility in Steatohepatitis	LITMUS	participant	15.797.881	56
2017-10-01	European Quality In Preclinical Data	EQIPD	participant	4.495.523	30
2017-09-01	Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management	eTRANSAFE	participant	20.000.000	27
2017-09-01	Targeting the metabolism-immune system connections in Cancer	META-CAN	participant	3.831.958	20
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-01-01	Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030	TransQST	participant	8.000.000	23
2016-09-01	Biomarker Enterprise to Attack DKD - Sofia ref.: 115974	BEAt-DKD	participant	15.085.937	31
2016-04-01	Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916	PRISM	participant	8.080.000	23
2016-03-01	Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924	VAC2VAC	participant	7.850.000	23
2016-01-01	Big Data in Chemistry	BIGCHEM	participant	2.540.146	17
2013-11-01	From DISCOvery to products: A next generation pipeline for the sustainable generation of high-value plant products	DISCO	participant	6.485.847	15
2012-10-01	Interdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders	TS-EUROTRAIN	participant	3.076.398	10
2012-04-01	Mucus Permeating Nanoparticulate Drug Delivery Systems	ALEXANDER	participant	8.098.202	18
2010-12-01	Transport and signalling in Polarized Cells	TRANSPOL	participant	3.835.980	11
2010-02-01	"Development of Vaccines for bTV, EHDV and AHSV"	ORBIVAC	participant	2.999.729	18
2010-01-01	New tools and approaches to control Porcine Reproductive and Respiratory Syndrome (PRRS) in the EU and Asia	PoRRSCon	participant	2.999.070	16

Alias institution names:

BOEHRIGER INGELHEIM INTERNATIONAL
BOEHRINGER INGELHEIM INTERNATIONALGMBH
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG
BOEHRINGER INGELHEIM RCV GMBH & CO KG
BOEHRINGER INGELHEIM VETMEDICA

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum